跳至主要内容
临床试验/NCT00537810
NCT00537810已完成4 期

Treatment of Binge Eating in Obese Patients in Primary Care

Yale University3 个研究点 分布在 1 个国家目标入组 104 人开始时间: 2007年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
104
试验地点
3
主要终点
BMI

研究概览

简要总结

This study will test the effectiveness of two empirically-supported but distinct treatments for recurrent binge eating in obese patients: 1) Cognitive Behavior Therapy, using a pure self-help approach and 2) sibutramine, an anti-obesity medication also found to have efficacy for binge eating. Self-help Cognitive Behavior Therapy and sibutramine will be administered alone and in combination in a primary care setting.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Obese (BMI >= 30)

排除标准

  • Medication regimen that represents medical contraindication to sibutramine
  • Serious unstable or uncontrolled medical conditions that represent contraindication to sibutramine
  • Pregnancy

研究组 & 干预措施

Sibutramine

Experimental

Sibutramine 15 mg daily

干预措施: Sibutramine (Drug)

Placebo

Placebo Comparator

Placebo Daily

干预措施: Placebo (Drug)

Placebo/CBTsh

Experimental

Placebo and Self-help CBT Placebo daily, Cognitive behavioral self-help manual for binge eating

干预措施: Self-help CBT + Sibutramine (Behavioral)

Sibutramine/CBTsh

Experimental

Sibutramine and Self-help CBT 15 mg daily Cognitive behavioral treatment manual for binge eating

干预措施: Self-help CBT + Placebo (Behavioral)

结局指标

主要结局

BMI

时间窗: 4 months

BMI (kg/m\^2) was measured 4 months after treatment.

Binge Eating (Remission)

时间窗: 4 months treatment; 6 and 12 month follow up post treatment

Remission from binge eating (zero binge episodes during previous 28 days)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Carlos Grilo

Professor of Psychiatry

Yale University

研究点 (3)

Loading locations...

相似试验